Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Omission of Bleomycin in Limited Stage Classic Hodgkin Lymphoma Patients with a Negative PET Scan Following 2 Cycles of ABVD Is Associated with Comparable Outcomes and Reduced Pulmonary Toxicity

Jiayu Yang, Diego Villa, Alina S. Gerrie, Petter Tonseth, Don C. Wilson, Francois Benard, Graham W. Slack, Christopher P. Venner, Andrea C. Lo, David W. Scott, Laurie H. Sehn, Kerry J. Savage

Blood (2024) 144 (Supplement 1): 461.

https://doi.org/10.1182/blood-2024-194858

Published: 2024

Journal Articles

Preclinical In Vivo Imaging of Multiple Myeloma with [ 18 f]Fluorohomoleucine (FHL) PET/CT

Milena Colovic, Matthew Nodwell, Leo Escano, Nadine Colpo, Ingrid Bloise, Gokce Engudar, Helen Merkens, Francois Benard, Paul Schaffer, Florian Kuchenbauer, Robert Britton

Blood (2023) 142 (Supplement 1): 1935.

https://doi.org/10.1182/blood-2023-188363

Published: 2023

Journal Articles

Long-Term Outcomes of High-Risk Stage 1/2 Classic Hodgkin Lymphoma Managed with an Advanced Stage Treatment Approach

Jowon Laura Kim, Diego Villa, R. Petter Tonseth, Alina S. Gerrie, Don Wilson, Francois Benard, Christopher P. Venner, Brian Skinnider, Pedro Farinha, Graham W. Slack, Randy D. Gascoyne, David W. Scott, Joseph M. Connors, Laurie H. Sehn, Kerry J. Savage

Blood (2022) 140 (Supplement 1): 9437–9438.

https://doi.org/10.1182/blood-2022-162199

Published: 2022

Journal Articles

Long-term results of PET-guided radiation in patients with advanced-stage diffuse large B-cell lymphoma treated with R-CHOP

Ciara L. Freeman, Kerry J. Savage, Diego R. Villa, David W. Scott, Line Srour, Alina S. Gerrie, Maura J. Brown, Graham W. Slack, Pedro Farinha, Brian Skinnider, James Morris, François Bénard, Christina Aquino-Parsons, Andrea Lo, Tom Pickles, Don C. Wilson, Petter Tonseth, Joseph M. Connors, Laurie H. Sehn

Blood (2021) 137 (7): 929–938.

https://doi.org/10.1182/blood.2020005846

Published: 2021

Includes: Supplemental data

Journal Articles

Outcome of primary mediastinal large B-cell lymphoma using R-CHOP: impact of a PET-adapted approach

Anna R. Hayden, Petter Tonseth, Derrick G. Lee, Diego Villa, Alina S. Gerrie, David W. Scott, Ciara L. Freeman, Graham W. Slack, Pedro Farinha, Brian Skinnider, Paul R. Yenson, Francois Benard, Andrea Lo, Tom Pickles, Donald Wilson, Joseph M. Connors, Laurie H. Sehn, Kerry J. Savage

Blood (2020) 136 (24): 2803–2811.

https://doi.org/10.1182/blood.2019004296

Published: 2020

Includes: Supplemental data

Journal Articles

Advanced Stage Classical Hodgkin Lymphoma Patients with a Negative PET-Scan Following Treatment with ABVD Have Excellent Outcomes without the Need for Consolidative Radiotherapy Regardless of Disease Bulk at Presentation

Kerry J. Savage, MDMSc, Joseph M. Connors, MD, Diego R Villa, MDMPH, Greg Hapgood, MD, Alina S Gerrie, MD, Tamara N Shenkier, MD, David W Scott, MBChB, PhD, Randy D. Gascoyne, Francois Benard, MD, James Morris, MD, Tom Pickles, MD, Christina Parsons, MD, Don Wilson, MD, Laurie H. Sehn

Blood (2015) 126 (23): 579.

https://doi.org/10.1182/blood.V126.23.579.579

Published: 2015

Journal Articles

Phase 2 Trial of Interim PET Scan-Tailored Therapy in Patients with Advanced Stage Diffuse Large B-Cell Lymphoma (DLBCL) in British Columbia (BC)

Laurie H Sehn, MD MPH, Edward L G Hardy, MD FRCPC, Karamjit K Gill, MD FRCPC, Abdulwahab J Al-Tourah, MBChB, FRCPC, Jesse Shustik, MD, Nicol A Macpherson, MDPhDFRCPC,, Adrian Yee, MD FRCPC, Wendy Lam, MD, Kerry J. Savage, MD MSc, Richard Klasa, MD CM, FRCP(C), Diego Villa, MDMPH, Alina S Gerrie, MD, Tamara Shenkier, MD, Graham W Slack, MD, Randy D. Gascoyne, MD, Francois Benard, MD, Don Wilson, MD, Peter Tonseth, MD, Joseph M Connors, MD

Blood (2014) 124 (21): 392.

https://doi.org/10.1182/blood.V124.21.392.392

Published: 2014

Journal Articles

FDG-PET Scan Guided Consolidative Radiation Therapy Optimizes Outcome In Patients with Advanced-Stage Diffuse Large B-Cell Lymphoma (DLBCL) with Residual Abnormalities on CT Scan Following R-CHOP

Laurie H. Sehn, MD, MPH, Paul Hoskins, MD, Richard Klasa, MD, Tamara Shenkier, MD, Randy D. Gascoyne, MD, Francois Benard, MD, Don Wilson, MD, James Morris, MD, Tom Pickles, MD, Joseph M. Connors, MD, Kerry J. Savage, MD

Blood (2010) 116 (21): 854.

https://doi.org/10.1182/blood.V116.21.854.854

Published: 2010

NARROW

Omission of Bleomycin in Limited Stage Classic Hodgkin Lymphoma Patients with a Negative PET Scan Following 2 Cycles of ABVD Is Associated with Comparable Outcomes and Reduced Pulmonary Toxicity

Preclinical In Vivo Imaging of Multiple Myeloma with [ 18 f]Fluorohomoleucine (FHL) PET/CT

Long-Term Outcomes of High-Risk Stage 1/2 Classic Hodgkin Lymphoma Managed with an Advanced Stage Treatment Approach

Long-term results of PET-guided radiation in patients with advanced-stage diffuse large B-cell lymphoma treated with R-CHOP

Outcome of primary mediastinal large B-cell lymphoma using R-CHOP: impact of a PET-adapted approach

Advanced Stage Classical Hodgkin Lymphoma Patients with a Negative PET-Scan Following Treatment with ABVD Have Excellent Outcomes without the Need for Consolidative Radiotherapy Regardless of Disease Bulk at Presentation

Phase 2 Trial of Interim PET Scan-Tailored Therapy in Patients with Advanced Stage Diffuse Large B-Cell Lymphoma (DLBCL) in British Columbia (BC)

FDG-PET Scan Guided Consolidative Radiation Therapy Optimizes Outcome In Patients with Advanced-Stage Diffuse Large B-Cell Lymphoma (DLBCL) with Residual Abnormalities on CT Scan Following R-CHOP

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only